Cargando…

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and (18)F-FDG PET/CT for radiotherapy target volume definition

PURPOSE: The aim of this study was to compare the pattern of intra-patient spread of lymph-node (LN)-metastases within the mediastinum as assessed by (18)F-FDG PET/CT and systematic endobronchial ultrasound-guided transbronchial-needle aspiration (EBUS-TBNA) for precise target volume definition in s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guberina, Maja, Darwiche, Kaid, Hautzel, Hubertus, Pöttgen, Christoph, Guberina, Nika, Gauler, Thomas, Ploenes, Till, Umutlu, Lale, Theegarten, Dirk, Aigner, Clemens, Eberhardt, Wilfried E. E., Metzenmacher, Martin, Wiesweg, Marcel, Karpf-Wissel, Rüdiger, Schuler, Martin, Herrmann, Ken, Stuschke, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442338/ https://www.ncbi.nlm.nih.gov/pubmed/34526050 http://dx.doi.org/10.1186/s13014-021-01904-4

Ejemplares similares

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
por: Guberina, Maja, et al.
Publicado: (2022)

Impact of EBUS-TBNA in addition to [(18)F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
por: Guberina, Maja, et al.
Publicado: (2021)

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
por: Guberina, Maja, et al.
Publicado: (2021)

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
por: Guberina, Nika, et al.
Publicado: (2022)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [(18)F]FDG PET/CT compared to the histopathology reference standard
por: Hautzel, Hubertus, et al.
Publicado: (2021)

[(68)Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
por: Guberina, Nika, et al.
Publicado: (2022)

Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
por: Hockmann, Jan, et al.
Publicado: (2023)

Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses
por: Oezkan, F, et al.
Publicado: (2014)

Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry
por: Pöttgen, Christoph, et al.
Publicado: (2023)

Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice
por: Guberina, M., et al.
Publicado: (2023)

Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of Sarcoidosis
por: Wälscher, J., et al.
Publicado: (2022)

Severe Pneumomediastinum Complicating EBUS-TBNA
por: Shweihat, Yousef, et al.
Publicado: (2015)

EBUS-TBNA for Diagnosis of Extrapulmonary Lesions
por: Jain, Deepali
Publicado: (2019)

Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer: The additional value of geometric over dosimetric parameters alone
por: Guberina, Nika, et al.
Publicado: (2023)

Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin
por: Guberina, Maja, et al.
Publicado: (2023)

Role of the Endobronchial Landmarks Guiding TBNA and EBUS-TBNA in Lung Cancer Staging
por: Arias, S., et al.
Publicado: (2016)

Role of EBUS-TBNA in the Diagnosis of Tuberculosis and Sarcoidosis
por: Gupta, Nalini, et al.
Publicado: (2019)

SUVmax—Δ makes the difference
por: Aigner, Clemens, et al.
Publicado: (2022)

Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial
por: Nour, Youness, et al.
Publicado: (2021)

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
por: Kraskowski, Oliver, et al.
Publicado: (2023)

Diagnostic yield of EBUS-TBNA for lymphoma and review of the literature
por: Erer, Onur Fevzi, et al.
Publicado: (2017)

Effects of Antithrombotic Treatment on Bleeding Complications of EBUS-TBNA
por: Gil, Hyun-Il, et al.
Publicado: (2021)

An unusual, life-threatening complication of EBUS-TBNA: Pneumoperitoneum
por: Söyler, Yasemin, et al.
Publicado: (2023)

A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA
por: Evison, Matthew, et al.
Publicado: (2014)

EBUS-TBNA in PET-positive lymphadenopathies in treated cancer patients
por: Guarize, Juliana, et al.
Publicado: (2017)

Evaluation of cytology in lung cancer diagnosis based on EBUS-TBNA
por: Dong, Zhengwei, et al.
Publicado: (2017)

Bronchial Fistula and Pneumomediastinum after EBUS-TBNA Following Mediastinoscopy
por: Bougioukas, Ioannis, et al.
Publicado: (2019)

The role of EBUS-TBNA in lung cancer restaging and mutation analysis
por: Muriana, Piergiorgio, et al.
Publicado: (2020)

Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image‐guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon
por: Levegrün, Sabine, et al.
Publicado: (2020)

MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics
por: Hoffmann, Christian, et al.
Publicado: (2023)

Yield of EBUS-TBNA for the diagnosis of sarcoidosis: impact of operator and cytopathologist experience
por: Navasakulpong, Asma, et al.
Publicado: (2016)

Role of EBUS TBNA in Staging of Lung Cancer: A Clinician's Perspective
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2019)

Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
por: Zarogoulidis, Paul, et al.
Publicado: (2021)

Efficacy and safety of EBUS‐TBNA under conscious sedation with meperidine and midazolam
por: Piro, Roberto, et al.
Publicado: (2022)

Role of EBUS-TBNA in Non-Neoplastic Mediastinal Lymphadenopathy: Review of Literature
por: Scano, Valentina, et al.
Publicado: (2022)

Successful Diagnosis of Epithelial Thymic Cancer Case Using EBUS-TBNA
por: Issa, Tammy, et al.
Publicado: (2022)

Prognostic Impact of EBUS TBNA for Lung Adenocarcinoma Patients with Postoperative Recurrences
por: Chen, Ying-Yi, et al.
Publicado: (2022)

Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

Pyopericardium and extensive mediastinal abscess following EBUS-TBNA for mediastinal staging of NSCLC: a case report
por: Hartert, Marc, et al.
Publicado: (2022)

Validation of EBUS-TBNA-integrated nodal staging in potentially node-positive non-small cell lung cancer
por: Sakairi, Yuichi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mkh8d7rir766fngfb9um3881t3